Abstract

THURSDAY, NOVEMBER 8, 2012
WORKSHOP A: Increasing Adoption of Diabetes Technology
Panel 1: Better Science
| 08:00 | Moderators: COL Karl Friedl, PhD U.S. Army TATRC, Fort Detrick, Maryland |
| Carol Herman, RN |
|
| 08:05 | How Cardiologists Have Successfully Adopted Technology for Atherosclerosis: Lessons for Diabetes Technology |
| 08:15 | New End Points for Diabetes Trials |
| 08:25 | Engaging Payers to Support Diabetes Technology |
| 08:35 | Q & A/Panel Discussion |
Panel 2: Better Products
| 09:05 | Human Factors for Diabetes Devices |
| 09:20 | Social Media to Promote Better Products |
| 09:35 | Q & A/Panel Discussion |
| 10:05 | Break |
Panel 3: Better Marketing
| 10:30 | Nonmedical Products: Marketing Ideas for Diabetes Products |
| 10:40 | Marketing Medical Products |
| 10:50 | Social Media Marketing |
| 11:00 | Q & A/Panel Discussion |
| 11:30 | End of workshop/Lunch |
WORKSHOP B: The Sensor–Tissue Interface
Panel 1: Academic
| 08:00 | Moderators: |
| Yogish C. Kudva, MBBS |
|
| 08:05 | Biomechanics of the Sensor-Tissue Interface |
| 08:22 | Single-Port Subcutaneous Glucose Monitoring at the Site of Insulin Delivery |
| 08:39 | Tissue Pathology |
| 08:56 | Tissue Engineering |
| 09:13 | Q & A/Panel Discussion |
| 09:35 | Break |
Panel 2: Industry
| 09:55 | Moderators: |
| Mike McShane, PhD |
|
| 10:00 | Inflammation, Miniaturization, and Sensitivity: The Three Critical Issues for a Robust Implantable Glucose Sensor |
| 10:17 | Application of the Implantable Continuous Glucose Monitoring System in a Human Subject |
| 10:34 | Improved Sensor Materials and Interface Demonstrate Improved Performance and Reliability in the DexCom G4 System |
| 10:51 | A Percutaneous Optical Fiber Glucose Sensor for Continuous Glucose Monitoring |
| 11:08 | Q & A/Panel Discussion |
| 11:30 | End of workshop/Lunch |
WORKSHOP C: Bolus Calculators for Insulin Dosing
Panel 1: Physiology
| 12:30 | Moderators: |
| Tessa Lebinger, MD |
|
| 12:35 | How the Pancreas Calculates Mealtime Release of Insulin |
| 12:52 | The Impact of Fat on Bolus Calculators |
| 13:09 | The Impact of Fat and Protein on Bolus Calculators |
| 13:26 | Bolus Calculators: The Good, The Bad, and The Ugly |
| 13:43 | Q & A/Panel Discussion |
| 14:05 | Break |
Panel 2: Clinical Applications
| 14:25 | Moderators: |
| W. Kenneth Ward, MD |
|
| 14:30 | Insulin Titration Supported by Automated Systems |
| 14:47 | Regulatory Aspects of Bolus Calculators for Insulin Dosing |
| 15:04 | Glucose-Information-Based Therapy Support: Evidence Base and Medical Value of Automated Insulin Bolus Calculation |
| 15:21 | Clinical Outcomes from Using Bolus Calculators |
| 15:38 | Q & A/Panel Discussion |
| 16:00 | End of workshop |
| 16:00–18:30 | Poster Session |
| 18:30–20:00 | Posters remain on display for viewing |
WORKSHOP D: Glycemic Variability
Panel 1: Clinical Applications
| 12:30 | Moderators: |
|
| 12:35 | Measuring Glycemic Variation: Metrics and Glycemic Data Sets—Limitations and Pitfalls |
|
| 12:52 | The Effect of Islet Transplantation on Glycemic Variability |
|
| 13:09 | The Impact of Glycemic Variability on Hospital Mortality |
|
| 13:26 | Glycemic Variability in Obese Patients |
|
| 13:43 | Q & A/Panel Discussion | |
| 14:05 | Break | |
Panel 2: New Metrics to Quantify Glycemic Variability
| 14:25 | Moderators: |
Marc Breton, PhD |
| 14:30 | A Novel Metric for Glycemic Variability |
|
| 14:47 | Quantifying the Distribution of Blood Glucose |
|
| 15:04 | Real-Time Calculation of Glycemic Variability to Improve Intensive Care Unit Patient Outcomes |
|
| 15:21 | Glycemic Variability Measured with Self-Monitoring of Blood Glucose |
|
| 15:38 | Q & A/Panel Discussion | |
| 16:00 | End of workshop | |
| 16:00–18:30 | Poster session | |
| 18:30–20:00 | Posters remain on display for viewing | |
